BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND PBX1, P40424, 5087 AND Treatment
8 results:

  • 1. Traditional Chinese Medicine in cancer Care: An Overview of 5834 Randomized Controlled Trials Published in Chinese.
    Lu CL; Li X; Zhou HM; Zhang C; Yang YY; Feng RL; Long CJ; Deng FY; Li JC; Cao ZM; Mao QY; Zhu JP; Hong YF; Huang SY; Qiu JY; Liu YX; Wang Y; Yan YQ; Dong JM; Luo YX; Chen YM; Guan YJ; Wieland LS; Robinson N; Liu JP
    Integr Cancer Ther; 2021; 20():15347354211031650. PubMed ID: 34261372
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Intrafraction motion during partial breast irradiation depends on treatment time.
    Hoekstra N; Habraken S; Swaak-Kragten A; Hoogeman M; Pignol JP
    Radiother Oncol; 2021 Jun; 159():176-182. PubMed ID: 33798609
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Nonlinear relationship between chromatin accessibility and estradiol-regulated gene expression.
    Chen D; Parker TM; Bhat-Nakshatri P; Chu X; Liu Y; Wang Y; Nakshatri H
    Oncogene; 2021 Feb; 40(7):1332-1346. PubMed ID: 33420376
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Diagnosing deficits in quality of life and providing tailored therapeutic options: Results of a randomised trial in 220 patients with colorectal cancer.
    Klinkhammer-Schalke M; Steinger B; Koller M; Zeman F; Fürst A; Gumpp J; Obermaier R; Piso P; Lindberg-Scharf P;
    Eur J Cancer; 2020 May; 130():102-113. PubMed ID: 32179445
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The Peptide ERα17p Is a GPER Inverse Agonist that Exerts Antiproliferative Effects in breast cancer Cells.
    Lappano R; Mallet C; Rizzuti B; Grande F; Galli GR; Byrne C; Broutin I; Boudieu L; Eschalier A; Jacquot Y; Maggiolini M
    Cells; 2019 Jun; 8(6):. PubMed ID: 31207943
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Perioperative inhibition of β-adrenergic and COX2 signaling in a clinical trial in breast cancer patients improves tumor Ki-67 expression, serum cytokine levels, and PBMCs transcriptome.
    Haldar R; Shaashua L; Lavon H; Lyons YA; Zmora O; Sharon E; Birnbaum Y; Allweis T; Sood AK; Barshack I; Cole S; Ben-Eliyahu S
    Brain Behav Immun; 2018 Oct; 73():294-309. PubMed ID: 29800703
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The pioneer factor pbx1 is a novel driver of metastatic progression in ERα-positive breast cancer.
    Magnani L; Patten DK; Nguyen VT; Hong SP; Steel JH; Patel N; Lombardo Y; Faronato M; Gomes AR; Woodley L; Page K; Guttery D; Primrose L; Fernandez Garcia D; Shaw J; Viola P; Green A; Nolan C; Ellis IO; Rakha EA; Shousha S; Lam EW; Győrffy B; Lupien M; Coombes RC
    Oncotarget; 2015 Sep; 6(26):21878-91. PubMed ID: 26215677
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Folate pathway gene expression differs in subtypes of acute lymphoblastic leukemia and influences methotrexate pharmacodynamics.
    Kager L; Cheok M; Yang W; Zaza G; Cheng Q; Panetta JC; Pui CH; Downing JR; Relling MV; Evans WE
    J Clin Invest; 2005 Jan; 115(1):110-7. PubMed ID: 15630450
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.